Genmab | GEN - Marktkapitalisierung

Aktienkurs
1,711.00
Täglich Wechseln
-32.50 -1.86%
Monatlich
2.30%
Jährlich
27.02%
Q2 Prognose
1,628.53




Marktkapitalisierung Veränderung Datum
Agios Pharmaceuticals USD 1.59B 745M 2025-12
Almirall EUR 2.76B 472.53M 2025-12
Amarin USD 290M 51M 2025-12
Amgen USD 176.25B 24.32B 2025-12
argenx SE USD 51.83B 7.52B 2025-12
AstraZeneca USD 288.15B 55.08B 2025-12
Bayer EUR 36.36B 9.13B 2025-12
BioMarin Pharmaceutical USD 11.42B 1.02B 2025-12
Demant DKK 46.01B 10.48B 2025-12
Exelixis USD 11.75B 959M 2025-12
Fresenius Medical Care EUR 11.96B 1.14B 2025-12
Galapagos EUR 1.85B 76.44M 2025-12
Genmab DKK 20.48B 1.02B 2025-12
GlaxoSmithKline GBP 74.36B 10.31B 2025-12
GN Store Nord DKK 16.11B 98.09M 2025-12
Hikma Pharmaceutical USD 4.63B 1.42B 2025-12
Insmed USD 37.12B 6.68B 2025-12
Lonza CHF 39.68B 980.61M 2025-06
Merck EUR 53.3B 5.72B 2025-12
Novartis USD 292.21B 26.55B 2025-12
Regeneron Pharmaceuticals USD 81.12B 21.53B 2025-12
Roche Holding CHF 266.34B 55.46B 2025-12
Sanofi EUR 101.43B 1.16B 2026-04
UCB EUR 46.41B 13.94B 2025-12